Does CRIZOTINIB Cause Bronchopulmonary aspergillosis? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Bronchopulmonary aspergillosis have been filed in association with CRIZOTINIB (Xalkori). This represents 0.2% of all adverse event reports for CRIZOTINIB.
22
Reports of Bronchopulmonary aspergillosis with CRIZOTINIB
0.2%
of all CRIZOTINIB reports
19
Deaths
15
Hospitalizations
How Dangerous Is Bronchopulmonary aspergillosis From CRIZOTINIB?
Of the 22 reports, 19 (86.4%) resulted in death, 15 (68.2%) required hospitalization, and 5 (22.7%) were considered life-threatening.
Is Bronchopulmonary aspergillosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRIZOTINIB. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does CRIZOTINIB Cause?
Death (2,028)
Neoplasm progression (1,161)
Nausea (820)
Disease progression (677)
Diarrhoea (631)
Vomiting (600)
Fatigue (419)
Off label use (353)
Dyspnoea (352)
Visual impairment (315)
What Other Drugs Cause Bronchopulmonary aspergillosis?
TACROLIMUS (968)
PREDNISONE (967)
DEXAMETHASONE (854)
CYCLOPHOSPHAMIDE (824)
METHYLPREDNISOLONE (794)
PREDNISOLONE (704)
MYCOPHENOLATE MOFETIL (702)
RITUXIMAB (606)
CYCLOSPORINE (583)
METHOTREXATE (553)
Which CRIZOTINIB Alternatives Have Lower Bronchopulmonary aspergillosis Risk?
CRIZOTINIB vs CROFELEMER
CRIZOTINIB vs CROMOLYN
CRIZOTINIB vs CROTALIDAE POLYVALENT IMMUNE FAB
CRIZOTINIB vs CUBICIN
CRIZOTINIB vs CUPRIC